Dear Doctor - Participate in the Survey on epilepsy " A new survey has found that nearly one in three people with epilepsy have experienced at least one seizure in the past year. The findings, from the Epilepsy Foundation's 2020 National Survey of Epilepsy Attitudes and Experiences, also reveal that half of all respondents worry about having a seizure in public."These survey results underscore the urgent need for improved access to care and treatments for people living with epilepsy," said Philip Gattone, CEO of the Epilepsy Foundation. "It is unacceptable that so many people with this condition are still facing challenges in getting the help they need."The survey, which was conducted online between February and March 2020, received more than 4,500 responses from people with epilepsy and their caregivers. Among other things, it found that:- 24% of respondents said they had not seen a doctor or other healthcare provider in the past year specifically for their epilepsy;- 36% said they have not been able to get all of the medication they need; and - 54% reported experiencing at least one seizure in the past year. Participate in Surveys "
1.
Examines Office-Based Transperineal Prostate Biopsies Methodology.
2.
Patients value communication skills from cancer surgeons across six key areas, according to research
3.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
1.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
2.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
5.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation